Measuring patient-relevant benefits in the treatment of psoriasis with the Patient Benefit Index: development and preliminary validation of a 10-item short form
Authors:
- Christine BlomeCBChristine Blome
- Catharina C. von StülpnagelCSCatharina C. von Stülpnagel
- Matthias AugustinMAMatthias Augustin
- Ulrich MrowietzUMUlrich Mrowietz
- Holger MuehlanHolger Muehlan
- Natalia KirstenNKNatalia Kirsten
- Anna K. LangenbruchALAnna K. Langenbruch
- Christina SorbeCSChristina Sorbe
- Toni M. KleinTKToni M. Klein
Open Access
- 1 October 2022
- journal article
- letter
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 187 (4) , 588-589
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Quality of psoriasis care in Germany – results from the nationwide health care studies PsoHealth 2004‐2017Journal of the European Academy of Dermatology and Venereology, 2021
- Topology of psoriasis in routine care: results from high‐resolution analysis of 2009 patientsBritish Journal of Dermatology, 2018
- Validation of the patient benefit index for the assessment of patient-relevant benefit in the treatment of psoriasisArchives of Dermatological Research, 2012
- The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseasesArchives of Dermatological Research, 2009
- Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology.Psychological Assessment, 1994
- Severe Psoriasis – Oral Therapy with a New RetinoidDermatology, 1978